---
title: "EAST-ASIA PHARMACEUTICAL: Levofloxacin Tablets Approved for Drug Registration Certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244398523.md"
description: "EAST-ASIA PHARMACEUTICAL recently obtained the drug registration certificate for Levofloxacin Tablets approved by the National Medical Products Administration. This drug is used to treat various infections. Several domestic manufacturers have already obtained registration certificates, and the national sales are expected to be approximately 435 million yuan in 2024. This certificate will positively impact the company's future development"
datetime: "2025-06-13T08:44:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244398523.md)
  - [en](https://longbridge.com/en/news/244398523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244398523.md)
---

# EAST-ASIA PHARMACEUTICAL: Levofloxacin Tablets Approved for Drug Registration Certificate

EAST-ASIA PHARMACEUTICAL announced that the company recently received the drug registration certificate for Levofloxacin Tablets issued by the National Medical Products Administration. This drug is a fluoroquinolone antibacterial agent used to treat mild to moderate infections of the respiratory system, urinary system, digestive system, skin and soft tissues, as well as infections in oral, ENT, ophthalmology, and dermatology. As of the announcement date, the main manufacturers in China that have obtained the drug registration certificate include Zhejiang Jingxin Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., and Beijing Jiluohua Pharmaceutical Co., Ltd. The national sales revenue for Levofloxacin Tablets in 2024 is approximately 435 million yuan. The company's acquisition of the drug registration certificate indicates that it is qualified to produce and sell this drug, which will have a positive impact on the company's future development

### Related Stocks

- [605177.CN](https://longbridge.com/en/quote/605177.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [Rare nickels that could fund your dreams](https://longbridge.com/en/news/286856785.md)
- [Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions](https://longbridge.com/en/news/286794376.md)